Simvastatin and Leukine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Simvastatin (simvastatin) and Leukine (sargramostim). Common drug interactions include sinus tachycardia among females and lymphadenopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Simvastatin and Leukine. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,969 Simvastatin users. Check the latest studies of Simvastatin.

What is Leukine?

Leukine has active ingredients of sargramostim. eHealthMe is studying from 2,188 Leukine users. Check the latest studies of Leukine.



On Jul, 29, 2026

51 people who take Simvastatin and Leukine together, and have interactions are studied.

Simvastatin and Leukine drug interactions.

What are the common drug interactions of Simvastatin and Leukine, by gender? *:

female:

  1. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  2. Transaminases increased
  3. Dizziness
  4. Anaphylactic reaction (serious allergic reaction)
  5. Body temperature increased
  6. Choking sensation (feeling of obstruction in respiratory system)
  7. Fall
  8. Hyperventilation
  9. Incoherent (talking in a confused and unclear way)
  10. Injection site irritation

male:

  1. Lymphadenopathy (disease or enlargement of lymph nodes)
  2. Hot flush (sudden feelings of heat)
  3. Osteonecrosis of jaw (death of bone of jaw)
  4. Anaemia (lack of blood)
  5. Skin lesion
  6. Infection
  7. Neoplasm malignant (cancer tumour)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  10. Bone density decreased

What are the common drug interactions of Simvastatin and Leukine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal distension
  2. Abdominal pain upper
  3. Abscess jaw (tooth abscess or root abscess)
  4. Actinomycosis (infection that causes sores, or abscesses)
  5. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Anaemia of chronic disease
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Anxiety
  10. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)

20-29:

n/a

30-39:

n/a

40-49:

  1. Headache (pain in head)
  2. Alanine aminotransferase increased

50-59:

  1. Myositis (inflammation of the muscles)
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Pyrexia (fever)
  4. Clostridial infection (infectious conditions by clostridium bacteria)
  5. Diarrhoea
  6. Infusion related reaction
  7. Metastases to central nervous system (cancer spreads to central nervous system)
  8. Metastatic malignant melanoma (spreadable cancer tumour of melanine)

60+:

  1. Lymphadenopathy (disease or enlargement of lymph nodes)
  2. Hot flush (sudden feelings of heat)
  3. Osteonecrosis of jaw (death of bone of jaw)
  4. Anaemia (lack of blood)
  5. Skin lesion
  6. Infection
  7. Neoplasm malignant (cancer tumour)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  10. Bone density decreased

What are the existing conditions these people have? *

  1. Prostate Cancer: 15 people, 29.41%
  2. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 7 people, 13.73%
  3. Gynecomastia (enlargement of the gland tissue of the male breast): 7 people, 13.73%
  4. Malignant Melanoma (skin cancer rises from melancytes): 6 people, 11.76%
  5. Osteopenia (a condition where bone mineral density is lower than normal): 5 people, 9.80%
  6. High Blood Pressure: 4 people, 7.84%
  7. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 7.84%
  8. Small Cell Lung Cancer Stage Unspecified (lung cancer in unknown stage): 3 people, 5.88%
  9. Multiple Myeloma (cancer of the plasma cells): 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Simvastatin and Leukine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Simvastatin and Leukine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Leukine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Leukine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin and sargramostim (the active ingredients of Simvastatin and Leukine, respectively), and Simvastatin and Leukine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: